The Swiss stock market experienced a decline mid-week, with the SMI index falling 0.21% to 12,193.07 points amid investor caution ahead of the European Central Bank's interest rate decision. Major losses were seen in luxury goods and technology sectors, particularly for Swatch Group and Richemont, following disappointing figures from LVMH. In contrast, stocks like Autoneum and Julius Baer showed gains, while Tecan plummeted 15% due to a forecast cut.
18:05 14.10.2024
UBS Group AG notified Solvay of a downward crossing of the 3% voting rights threshold on October 7, 2024, due to a reduction in holdings in its trading portfolio. Following this adjustment, UBS's total indirect interest in Solvay's voting rights fell below 3%, triggering the disclosure obligation. Solvay, committed to sustainable chemistry, reported net sales of 4.9 billion euros in 2023 and aims for carbon neutrality by 2050.
17:45 14.10.2024
UBS Group AG notified Solvay that it crossed a transparency threshold, reducing its indirect voting rights below 3% as of October 7, 2024, due to a decrease in Trading Book holdings. This notification aligns with Belgian transparency legislation, reflecting UBS's controlled undertakings' holdings. Solvay, a leading chemical company with a commitment to sustainability and a goal of carbon neutrality by 2050, reported €4.9 billion in net sales in 2023 and employs over 9,000 people globally.
17:45 14.10.2024
J.P. Morgan Asset Management is restructuring its alternatives business to enhance its competitive edge in private markets, led by executives with extensive experience. With $400 billion in alternative assets, the firm aims to better serve wealthy individual investors and family offices through tailored products, including evergreen funds and co-investment opportunities. This strategic shift reflects a commitment to active management and leveraging its private banking history to meet growing demand in the private credit and equity sectors.
adidas shares rose over 1% following UBS's positive analysis, which confirmed a Buy recommendation and raised the price target to €279 from €275, indicating a potential upside of 19%. The company anticipates high single-digit revenue growth for 2024, with operating profit expected to reach around €1 billion, up from a previous estimate of €700 million.
17:11 14.10.2024
adidas shares rose over 1% following a positive analysis from UBS, which raised its price target to €279 from €275, indicating a potential upside of 19%. The analyst highlighted continued sales growth exceeding 10% and revised revenue expectations for 2024 to a high single-digit rate, with operating profit projected around €1 billion.
17:11 14.10.2024
OMNY Health has appointed Ivy Weng as chief commercial officer to enhance its market presence in life sciences and AI. Cityblock Health welcomes Michael Roaldi as president, while Counterpart Health names David Tsay, M.D., Ph.D., as chief medical officer to advance its clinical strategy. Other notable appointments include Ashish Pagey at ShiftKey and new executives at Ada Health.
Elite Pharmaceuticals, Inc. has announced its financial results for the first quarter of fiscal year 2025, which ended on June 30, 2024. The company also provided details regarding an upcoming conference call to discuss these results further.
UBS forecasts a decline in traffic around Paris due to potential increases in aviation taxes, maintaining a neutral stance on ADP. The bank suggests that a 10% price hike could lead to a 2% drop in passenger numbers, particularly affecting low-cost airline customers, emphasizing the critical link between traffic growth and EBITDA performance.
16:59 14.10.2024
A group of campaigners is urging the U.S. Department of Labor to revoke UBS's exemption allowing it to operate in the American pension market, citing the bank's history of nearly 100 offenses and $20 billion in penalties since 2000. UBS, which has submitted a 500-page application to extend its exemption, argues that issues stem from individual staff actions. Recent legal troubles include a significant fine in France for tax evasion and involvement in an antitrust lawsuit related to interest rate swaps.
16:41 14.10.2024
Trending
Subcategory:
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings